SCOTUS Upholds Mifepristone Access
The U.S. Supreme Court unanimously rejected a challenge to the Food and Drug Administration's (FDA) regulations for mifepristone, ensuring the widely used abortion pill remains accessible under its current rules nationwide. This pivotal decision, issued Thursday, found that anti-abortion groups lacked legal standing to sue, thereby preventing a major nationwide restriction on reproductive healthcare access.